SCHEMBL368190

SCHEMBL368190

NNC1=CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5111096 0.97
SCHEMBL12335600 0.92
SCHEMBL49260 0.78 HDAC4 (0.38)
SCHEMBL1485620 0.76 HDAC4 (0.37)
SCHEMBL1485619 0.76 HDAC4 (0.37)
SCHEMBL8474760 0.76 HDAC4 (0.37)
SCHEMBL7803142 0.76 HDAC4 (0.37)
SCHEMBL723756 0.74
SCHEMBL5807465 0.74
SCHEMBL510008 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022122846-A1 ETHODS OF DETECTING ALDEHYDES IN SAMPLES LONZA LTD (CH) 2022-06-16 WO disclosed
EP-2415476-A1 COMPOSITION FOR TREATMENT AND/OR PREVENTION OF DERMATOPATHY Lotte Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120015063-A1 COMPOSITION FOR TREATMENT AND/OR PREVENTION OF SKIN DISORDER LOTTE CO., LTD. (JP) 2012-01-19 US disclosed
EP-0987332-B1 DNA encoding a polypeptide having stereoselective transaminase activity, and transformants comprising said DNA KANEKA CORP (JP) 2009-08-19 EP disclosed
EP-1045025-B1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE KANEKA CORP (JP) 2008-10-22 EP disclosed
US-7169592-B2 Producing optically active amino compounds KANEKA CORPORATION (JP) 2007-01-30 US disclosed
EP-0857790-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS KANEKA CORP (JP) 2005-08-17 EP disclosed
EP-1230244-B1 PYRAZOLECARBOXYLIC ACID TRICYCLIC DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI AVENTIS (FR) 2005-01-19 EP disclosed
US-20020192786-A1 Producing optically active amino compounds KANEKA CORPORATION 2002-12-19 US disclosed
EP-1230244-A2 PYRAZOLECARBOXYLIC ACID TRICYCLIC DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Sanofi-Aventis (FR) 2002-08-14 EP disclosed
US-6346402-B1 ACTS ON OPTICALLY ACTIVE (S)-ALPHA-PHENETHYLAMINE AND PYRUVIC ACID TO FORM ACETOPHENONE AND ALANINE; FOR PRODUCING CHEMICAL INTERMEDIATES OF DRUGS AND AGRICULTURAL CHEMICALS KANEKA CORPORATION (JP) 2002-02-12 US disclosed
US-6344351-B2 USING (R)-FORM-SPECIFIC TRANSAMINASE WITH KETONE AMINO ACCEPTOR AND AMINO DONOR; ANTIDIABETES AND ANTIOBESITY AGENTS KANEKA CORPORATION (JP) 2002-02-05 US disclosed
US-20010031487-A1 Process for producing optically active amino compounds KANEKA CORPORATION 2001-10-18 US disclosed
WO-2001032663-A2 PYRAZOLECARBOXYLIC ACID TRICYCLIC DERIVATIVES, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI-SYNTHELABO (FR) 2001-05-10 WO disclosed
US-6221638-B1 BY STEREOSELECTIVELY CARRYING OUT AMINO GROUP TRANSFER BY ACTION OF AN (R)-FORM-SPECIFIC TRANSAMINASE IN THE CO-PRESENCE OF A KETONE (AMINO ACCEPTOR) AND AMINO COMPOUND (AMINO DONOR); YIELDS AMINO COMPOUNDS HAIVNG ARYL GROUP AT THE 1-POSITION KANEKA CORPORATION (JP) 2001-04-24 US disclosed
EP-1045025-A1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE KANEKA CORPORATION (JP) 2000-10-18 EP disclosed
EP-0987332-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS Kaneka Corporation (JP) 2000-03-22 EP disclosed
EP-0857790-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS KANEKA CORPORATION (JP) 1998-08-12 EP disclosed